Peptide Initiative
Back to Ularitide

Clinical trials

Every registered trial of Ularitide

5 studies.

Plain-Language Summary

Plain-language reading of the public trial registries.

In short

  • Very little human research on Ularitide has been registered.
  • 5 registered studies in total.
  • None are currently enrolling — this research has already happened.

What kind of research

  • 5 studies actually gave the peptide to volunteers and measured what happened. This is the kind of study that can show whether something works.
  • About 2,241 people took part in those.

A registered trial is a plan, not a result. Registration means a study was declared in advance; it says nothing about whether the peptide worked, and a trial can be registered and then abandoned.

Filter

Showing 5 of 5 trials for Ularitide.

  • NCT04311489 Phase 2Terminated17 enrolled2020

    Refractory Ascites in Patients With Liver Cirrhosis, and the Potential Treatment With 48 Hours Infusion of Ularitide.

    University of Aarhus

    Cirrhosis, Liver · Ascites Hepatic

  • NCT01661634 Phase 3Completed2,157 enrolled2012

    Efficacy and Safety of Ularitide for the Treatment of Acute Decompensated Heart Failure

    Cardiorentis

    Acute Decompensated Heart Failure

  • NCT00390624 Phase 2Completed20 enrolled2003

    Prevention Of Nephrotoxicity Following Bone Marrow Transplantation Using Urodilatin and Mannitol

    Rocky Mountain Cancer Centers

    Renal Dysfunction · Acute Renal Failure · Mortality

  • The natriuretic and diuretic effects of urodilatin in cirrhosis patients with severe sodium retention

    Aarhus University Hospital (Denmark)

    Decompensated liver cirrhosis.

  • NCT00487799 Phase 1Withdrawn32 enrolled

    A Study of Ularitide in the Treatment of Subjects With Acute Decompensated Heart Failure

    Facet Biotech

    Heart Failure, Congestive

Sources: ClinicalTrials.gov, the EU Clinical Trials Information System and ISRCTN, deduplicated so a study registered in more than one registry is counted once. A study is listed when Ularitide is named as an intervention. A registered trial is a plan, not a result — registration says nothing about whether the peptide worked.